Skip to main content

Table 2 Concordance analysis

From: Epidemiological evaluation of concordance between initial diagnosis and central pathology review in a comprehensive and prospective series of sarcoma patients in the Rhone-Alpes region

   Concordance

Zero

Partial

Full

p

   Included tumors

70 (100%)

97 (100%)

199 (100%)

 

Type of laboratory

    

   Public

17 (16.8%)

28 (27.7%)

56 (55.4%)

0.78

   Private

53 (20%)

69 (26.%)

143 (54%)

 

   Concordance

Zero

Partial

Full

p

   Included tumors

70

97

97

 

Type of tumor sample

    

   Biopsy

16 (17.2%)

23 (24.7%)

54 (58.1%)

0.70

   Surgical specimen

54 (19.8%)

74 (27.1%)

145 (53.1%)

 

Concordance

Zero

Partial

Full

p

   Included tumors

44

81

134

 

Grade

    

   I

9 (10.6%)

21 (24.7%)

55 (64.7%)

0.01

   II-III

35 (20.1%)

60 (34.5%)

79 (45.4%)

 

Concordance

Zero

Partial

Full

p

   Included tumors

67

97

199

 

Molecular biology study

    

   No

45 (20%)

61 (26.%)

127 (54%)

0.84

   Yes

23(17.6%)

36 (27.5%)

72 (55.0%)